Rocatinlimab | Interleukin Related interleukin-related.com

Product Name :
Rocatinlimab

Search keywords :
OX40L

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 4

Target Vo Short Name :
OX40

Moa_Name:
Tumor necrosis factor receptor superfamily member 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kyowa Hakko Kirin Co Ltd

Active Company_Name :
Amgen Biotechnology Consultation (Shanghai) Co Ltd

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:
Intestinal Diseases

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HDAC4 Antibody
Histone H3 (tri methyl K9) Antibody
AMPK beta 1 Antibody: AMPK beta 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 30 kDa, targeting to AMPK beta 1. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts